Ibrutinib and TGR-1202 Combo Encouraging Relapsed Leukemia or Lymphoma

Ibrutinib and TGR-1202 Combo Encouraging Relapsed Leukemia or Lymphoma

User Photo
ASHReport

4 years
759 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jennifer Brown, MD of Dana Farber, discusses a promising study that combines Ibrutinib with TGR-1202 and its results at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay
>